Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Arkenau, H.T.
83  Ergebnisse:
Personensuche X
?
1

Pooled safety analysis from phase III studies of trifluridi..:

Van Cutsem, E. ; Hochster, H. ; Shitara, K....
ESMO Open.  7 (2022)  6 - p. 100633 , 2022
Link: https://doi.org/10.1016/..
 
?
2

PB2099: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-1607, A FIRST-..:

Sharp, A. ; Williams, A. ; Blagden, S....
HemaSphere.  6 (2022)  - p. 1970-1971 , 2022
Link: https://doi.org/10.1097/..
 
?
3

Quality of life with encorafenib plus cetuximab with or wit..:

Kopetz, S. ; Grothey, A. ; Van Cutsem, E....
ESMO Open.  7 (2022)  3 - p. 100477 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Trifluridine/tipiracil versus placebo for third or later li..:

Tabernero, J. ; Shitara, K. ; Zaanan, A....
ESMO Open.  6 (2021)  4 - p. 100200 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Phase I, first-in-human study of futibatinib, a highly sele..:

Bahleda, R. ; Meric-Bernstam, F. ; Goyal, L....
Annals of Oncology.  31 (2020)  10 - p. 1405-1412 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Lymph node-only metastatic gastric/gastroesophageal junctio..:

Formica, V. ; Morelli, C. ; Patrikidou, A....
Gastric Cancer.  23 (2020)  6 - p. 1107-1108 , 2020
Link: https://doi.org/10.1007/..
 
?
7

Tisotumab vedotin (TV) in patients with previously treated ..:

Hong, D.S. ; Arkenau, H.T. ; de Bono, J....
Gynecologic Oncology.  154 (2019)  - p. 11-12 , 2019
Link: https://doi.org/10.1016/..
 
?
8

An extended phase Ib study of epertinib, an orally active r..:

Arkenau, H.-T. ; Italiano, A. ; Mak, G....
European Journal of Cancer.  103 (2018)  - p. 17-23 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Towards an Optimal Treatment Algorithm for Metastatic Pancr..:

Uccello, M. ; Moschetta, M. ; Mak, G....
Current Oncology.  25 (2018)  1 - p. 90-94 , 2018
Link: https://doi.org/10.3747/..
 
?
10

Biological and predictive role of ERCC1 polymorphisms in ca..:

Formica, V. ; Doldo, E. ; Antonetti, F.R....
Critical Reviews in Oncology/Hematology.  111 (2017)  - p. 133-143 , 2017
Link: https://doi.org/10.1016/..
 
?
11

A phase I dose escalation, safety and pharmacokinetic (PK) ..:

Chowdhury, S. ; Burris III, H.A. ; Patel, M....
European Journal of Cancer.  69 (2016)  - p. S145 , 2016
Link: https://doi.org/10.1016/..
 
?
12

1571 Ideal Body Mass Index (BMI) is significantly different..:

Formica, V. ; Pellicori, S. ; Arkenau, H.T....
European Journal of Cancer.  51 (2015)  - p. S228 , 2015
Link: https://doi.org/10.1016/..
 
?
13

27LBA Evidence of activity of a new mechanism of action (Mo..:

Arkenau, H.T. ; Voskoboynik, M. ; Infante, J....
European Journal of Cancer.  51 (2015)  - p. S724 , 2015
Link: https://doi.org/10.1016/..
 
?
14

2364 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in pat..:

Chung, H.C. ; Arkenau, H.T. ; Wyrwicz, L....
European Journal of Cancer.  51 (2015)  - p. S457 , 2015
Link: https://doi.org/10.1016/..
 
?
15

A Phase 1 Trial of X-396, a Novel ALK Inhibitor, in Patient..:

Horn, L. ; Blumenscheine, G. ; Wakelee, H.A....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  5 - p. S52-S53 , 2014
Link: https://doi.org/10.1016/..
 
1-15